ThePrintPod: Big pharma pivoting to more lucrative obesity segment, Indian drugmakers eye insulin market

ThePrint
02/06/2025 3 min Episodio 8425
ThePrintPod: Big pharma pivoting to more lucrative obesity segment, Indian drugmakers eye insulin market

Listen "ThePrintPod: Big pharma pivoting to more lucrative obesity segment, Indian drugmakers eye insulin market"

Descargar episodio Ver en sitio original

Episode Synopsis



The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady entry into a market once dominated by Big pharma.




 

More episodes of the podcast ThePrint

ThePrintAM: What have experts said on the Delhi cloud-seeding trial? 29/10/2025
WritingsOnTheWall: When Writings on the Wall predicted Nitish's win in 2010 & read Bihar's changing political equations 28/10/2025
ThePrintAM: Who is Lakhwinder Singh, Lawrence Bishnoi aide deported from US? 28/10/2025
CutTheClutter: All about India's largest hydroelectric dam, the 2000MW Lower Subansiri Project in Arunachal Pradesh 28/10/2025
ThePrintAM: What did PM Modi say about India-ASEAN ties in his virtual address at the ongoing ASEAN Summit? 27/10/2025
NationalInterest: Deepfake on duty: When Shekhar Gupta asked AI to read Op Sindoor citations 25/10/2025
CutTheClutter: Challenges for Japan's 1st female PM Sanae Takaichi & a primer on country’s politics,military policy 25/10/2025
ThePrintPod: Days after Lahore violence, Pakistan bans far-Right TLP for ‘terrorist activities’, second time in 4 yrs 24/10/2025
ThePrintPod: Indian universities follow the same template on sexual assault—cover up, blame the victim 24/10/2025
ThePrintAM: What's behind INDIA bloc's move to name Tejashwi Yadav as Bihar CM face? 24/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA